Comparison of MRI, MRA, and DSA for Detection of Cerebral Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia.


Journal

AJNR. American journal of neuroradiology
ISSN: 1936-959X
Titre abrégé: AJNR Am J Neuroradiol
Pays: United States
ID NLM: 8003708

Informations de publication

Date de publication:
06 2020
Historique:
received: 30 01 2020
accepted: 26 03 2020
pubmed: 10 5 2020
medline: 24 11 2020
entrez: 9 5 2020
Statut: ppublish

Résumé

Patients with hereditary hemorrhagic telangiectasia (HHT) have a high prevalence of brain vascular malformations, putting them at risk for brain hemorrhage and other complications. Our aim was to evaluate the relative utility of MR imaging and MRA compared with DSA in detecting cerebral AVMs in the HHT population. Of 343 consecutive patients evaluated at the University of California, San Francisco HTT Center of Excellence, 63 met the study inclusion criteria: definite or probable hereditary hemorrhagic telangiectasia defined by meeting at least 2 Curacao criteria or positive genetic testing, as well as having at least 1 brain MR imaging and 1 DSA. MRIs were retrospectively reviewed, and the number of AVMs identified was compared with the number of AVMs identified on DSA. Of 63 patients, 45 (71%) had AVMs on DSA with a total of 92 AVMs identified. Of those, 24 (26%) were seen only on DSA; 68 (74%), on both DSA and MR imaging; and 5 additional lesions were seen only on MR imaging. Of the 92 lesions confirmed on DSA, 49 (53.3%) were seen on the 3D-T1 postgadolinium sequence, 52 (56.5%) were seen on the 2D-T1 postgadolinium sequence, 35 (38.0%) were seen on the SWI sequence, 24 (26.1%) were seen on T2 sequence, and 25 (27.2%) were seen on MRA. The sensitivity and specificity of MR imaging as a whole in detecting AVMs then confirmed on DSA were 80.0% and 94.4%, respectively, and the positive and negative predictive values were 97.3% and 65.4%, respectively. This study reinforces the use of MR imaging as a primary screening tool for cerebral AVMs in patients with hereditary hemorrhagic telangiectasia and suggests that 3D-T1 postgadolinium and 2D-T1 postgadolinium performed at 3T are the highest yield sequences.

Sections du résumé

BACKGROUND AND PURPOSE
Patients with hereditary hemorrhagic telangiectasia (HHT) have a high prevalence of brain vascular malformations, putting them at risk for brain hemorrhage and other complications. Our aim was to evaluate the relative utility of MR imaging and MRA compared with DSA in detecting cerebral AVMs in the HHT population.
MATERIALS AND METHODS
Of 343 consecutive patients evaluated at the University of California, San Francisco HTT Center of Excellence, 63 met the study inclusion criteria: definite or probable hereditary hemorrhagic telangiectasia defined by meeting at least 2 Curacao criteria or positive genetic testing, as well as having at least 1 brain MR imaging and 1 DSA. MRIs were retrospectively reviewed, and the number of AVMs identified was compared with the number of AVMs identified on DSA.
RESULTS
Of 63 patients, 45 (71%) had AVMs on DSA with a total of 92 AVMs identified. Of those, 24 (26%) were seen only on DSA; 68 (74%), on both DSA and MR imaging; and 5 additional lesions were seen only on MR imaging. Of the 92 lesions confirmed on DSA, 49 (53.3%) were seen on the 3D-T1 postgadolinium sequence, 52 (56.5%) were seen on the 2D-T1 postgadolinium sequence, 35 (38.0%) were seen on the SWI sequence, 24 (26.1%) were seen on T2 sequence, and 25 (27.2%) were seen on MRA. The sensitivity and specificity of MR imaging as a whole in detecting AVMs then confirmed on DSA were 80.0% and 94.4%, respectively, and the positive and negative predictive values were 97.3% and 65.4%, respectively.
CONCLUSIONS
This study reinforces the use of MR imaging as a primary screening tool for cerebral AVMs in patients with hereditary hemorrhagic telangiectasia and suggests that 3D-T1 postgadolinium and 2D-T1 postgadolinium performed at 3T are the highest yield sequences.

Identifiants

pubmed: 32381546
pii: ajnr.A6549
doi: 10.3174/ajnr.A6549
pmc: PMC7342764
doi:

Types de publication

Comparative Study Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

969-975

Subventions

Organisme : NIBIB NIH HHS
ID : R01 EB012031
Pays : United States
Organisme : NIBIB NIH HHS
ID : T32 EB001631
Pays : United States

Informations de copyright

© 2020 by American Journal of Neuroradiology.

Références

AJNR Am J Neuroradiol. 2015 May;36(5):863-70
pubmed: 25572952
Stroke. 2012 May;43(5):1240-6
pubmed: 22308253
AJNR Am J Neuroradiol. 1998 Mar;19(3):477-84
pubmed: 9541302
Radiology. 1995 Jul;196(1):187-93
pubmed: 7784565
Neurosurgery. 1992 Apr;30(4):522-8
pubmed: 1584350
J Neurointerv Surg. 2017 Jan;9(1):26-28
pubmed: 26919971
J Neurol Neurosurg Psychiatry. 2003 Jun;74(6):743-8
pubmed: 12754343
Eur Radiol. 2006 Mar;16(3):583-91
pubmed: 16220210
J Neurosurg. 2000 May;92(5):779-84
pubmed: 10794291
Neurosurgery. 2016 May;78(5):684-93
pubmed: 26540357
AJNR Am J Neuroradiol. 2014 Jul;35(7):1376-80
pubmed: 24627452
Am J Med Genet. 2000 Mar 6;91(1):66-7
pubmed: 10751092
Stroke. 2001 Apr;32(4):877-82
pubmed: 11283386
J Med Genet. 2011 Feb;48(2):73-87
pubmed: 19553198
AJNR Am J Neuroradiol. 2015 May;36(5):949-52
pubmed: 25634722
Neuroradiology. 2003 Jan;45(1):27-33
pubmed: 12525951

Auteurs

M Vella (M)

From the Departments of Radiology and Biomedical Imaging (M.V.).

M D Alexander (MD)

Department of Radiology, Division of Interventional Neuroradiology (M.D.A.), University of Utah, Salt Lake City, Utah.

M C Mabray (MC)

Department of Radiology, Division of Neuroradiology (M.C.M.), University of New Mexico, Albuquerque, New Mexico.

D L Cooke (DL)

Division of Neurointerventional Radiology (D.L.C., M.R.A., D.E.L., S.W.H.).

M R Amans (MR)

Division of Neurointerventional Radiology (D.L.C., M.R.A., D.E.L., S.W.H.).

C M Glastonbury (CM)

Division of Diagnostic Neuroradiology (C.M.G.).

H Kim (H)

Hereditary Hemorrhagic Telangiectasia Center of Excellence (H.K., D.E.L., M.B.C., S.W.H.).
Anesthesia and Perioperative Care (H.K.), University of California, San Francisco, San Francisco, California.

M W Wilson (MW)

Division of Interventional Radiology (M.W.W., M.B.C.).

D E Langston (DE)

Division of Neurointerventional Radiology (D.L.C., M.R.A., D.E.L., S.W.H.).
Hereditary Hemorrhagic Telangiectasia Center of Excellence (H.K., D.E.L., M.B.C., S.W.H.).

M B Conrad (MB)

Division of Interventional Radiology (M.W.W., M.B.C.).
Hereditary Hemorrhagic Telangiectasia Center of Excellence (H.K., D.E.L., M.B.C., S.W.H.).

S W Hetts (SW)

Division of Neurointerventional Radiology (D.L.C., M.R.A., D.E.L., S.W.H.) steven.hetts@ucsf.edu.
Hereditary Hemorrhagic Telangiectasia Center of Excellence (H.K., D.E.L., M.B.C., S.W.H.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH